DE4421159C1 - Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche - Google Patents

Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche

Info

Publication number
DE4421159C1
DE4421159C1 DE4421159A DE4421159A DE4421159C1 DE 4421159 C1 DE4421159 C1 DE 4421159C1 DE 4421159 A DE4421159 A DE 4421159A DE 4421159 A DE4421159 A DE 4421159A DE 4421159 C1 DE4421159 C1 DE 4421159C1
Authority
DE
Germany
Prior art keywords
oxide
immune deficiency
iii
iron
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE4421159A
Other languages
German (de)
English (en)
Inventor
Thomas Bruns
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE4421159A priority Critical patent/DE4421159C1/de
Priority to PCT/DE1995/000758 priority patent/WO1995035113A1/de
Priority to JP8501466A priority patent/JPH10507157A/ja
Application granted granted Critical
Publication of DE4421159C1 publication Critical patent/DE4421159C1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE4421159A 1994-06-20 1994-06-20 Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche Expired - Fee Related DE4421159C1 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE4421159A DE4421159C1 (de) 1994-06-20 1994-06-20 Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche
PCT/DE1995/000758 WO1995035113A1 (de) 1994-06-20 1995-06-19 VERWENDUNG VON EISEN (III)-OXID (Fe2O3) BEI IMMUNSCHWÄCHE, INSBESONDERE AIDS
JP8501466A JPH10507157A (ja) 1994-06-20 1995-06-19 鉄（ｉｉｉ）酸化物の使用方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4421159A DE4421159C1 (de) 1994-06-20 1994-06-20 Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche

Publications (1)

Publication Number Publication Date
DE4421159C1 true DE4421159C1 (de) 1995-08-24

Family

ID=6520801

Family Applications (1)

Application Number Title Priority Date Filing Date
DE4421159A Expired - Fee Related DE4421159C1 (de) 1994-06-20 1994-06-20 Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche

Country Status (3)

Country Link
JP (1) JPH10507157A (ja)
DE (1) DE4421159C1 (ja)
WO (1) WO1995035113A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1627641A1 (en) * 2004-08-04 2006-02-22 Victor Eluwa Pharmaceutical compositions comprising metal oxides and uses thereof
ES2333814T3 (es) 2005-02-09 2010-03-01 Vifor (International) Ag Uso de compuestos de complejo de hierro (iii).
EP1757299A1 (de) 2005-08-25 2007-02-28 Vifor (International) Ag Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0307914A2 (en) * 1987-09-18 1989-03-22 F. Hoffmann-La Roche Ag Pharmaceutical compositions containing a dideoxynucleoside
WO1990007322A1 (en) * 1988-12-19 1990-07-12 David Gordon Diagnosis and treatment of viral effects
EP0516252A2 (de) * 1991-05-28 1992-12-02 INSTITUT FÜR DIAGNOSTIKFORSCHUNG GmbH AN DER FREIEN UNIVERSITÄT BERLIN Nanokristalline magnetische Eisenoxid-Partikel zur Anwendung in Diagnostik und Therapie
EP0584558A2 (en) * 1992-07-28 1994-03-02 Snow Brand Milk Products Co., Ltd. A composition for suppressing infection and growth of human immunodeficiency virus using an iron-binding protein

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2527158A1 (de) * 1975-06-18 1976-12-23 Herz Eberhard Arzneimittel zur behandlung von infektionskrankheiten und von nicht nachweisbar durch mikroorganismen ausgeloeste entzuendungen in der human- und veterinaermedizin
JPS59190226A (ja) * 1983-04-11 1984-10-29 Shoji Yamashita 二価三価鉄塩およびその製造方法
WO1993003035A1 (en) * 1991-08-02 1993-02-18 Meiji Milk Products Co., Ltd. Anti-hiv drug

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0307914A2 (en) * 1987-09-18 1989-03-22 F. Hoffmann-La Roche Ag Pharmaceutical compositions containing a dideoxynucleoside
WO1990007322A1 (en) * 1988-12-19 1990-07-12 David Gordon Diagnosis and treatment of viral effects
EP0516252A2 (de) * 1991-05-28 1992-12-02 INSTITUT FÜR DIAGNOSTIKFORSCHUNG GmbH AN DER FREIEN UNIVERSITÄT BERLIN Nanokristalline magnetische Eisenoxid-Partikel zur Anwendung in Diagnostik und Therapie
EP0584558A2 (en) * 1992-07-28 1994-03-02 Snow Brand Milk Products Co., Ltd. A composition for suppressing infection and growth of human immunodeficiency virus using an iron-binding protein

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DE P44 19 256.8-41(ält. Anmeldung) *
WARREN, J., et. al.: J. Immunol. 1969, 102 (5), S. 1300 - 1308 *

Also Published As

Publication number Publication date
WO1995035113A1 (de) 1995-12-28
JPH10507157A (ja) 1998-07-14

Similar Documents

Publication Publication Date Title
DE3789239T2 (de) Pharmazeutische Zusammensetzung enthaltend Interferon für bukkale Verabreichung.
CN105189607B (zh) 胺官能性聚酰胺
DE69028775T2 (de) Antivirale therapie unter verwendung von thiazin- und xanthenfarbstoffen
CH660970A5 (de) Verfahren zur herstellung antibakterieller methylol-transfer-mittel.
DE3444765A1 (de) Immunmodulierendes arzneimittel
DE2710327A1 (de) Carcinostatisches mittel
US20060105057A1 (en) Compositions using tetrasilver tetroxide and methods for management of skin conditions using same
DE4421159C1 (de) Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche
DE19506742A1 (de) Verwendung von Chinoxalinen in Kombination mit Protease-Inhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen
DE3638124C2 (de) Neue pharmazeutische Verwendung von Ebselen
EP0607777B1 (de) Verwendung von Leflunomid zur Hemmung von Interleukin 8
SPAETH et al. Treatment of Trichinosis: Case Report
SK94297A3 (en) New applications of lysozyme dimer
DE69929616T2 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
DE4300969C2 (de) Verwendung von Malotilat zum Beschleunigen der Wundheilung bei Hautverbrennungen
DE68915154T2 (de) Anwendung von gegen retroviren aktiven wirkstoffen und so erhaltene produkte.
DE68907569T2 (de) Mittel zur Behandlung oder Vorbeugung von Aids.
DE102005037096A1 (de) Neues Arzneimittel gegen AIDS und HIV-Vieren
DE69511453T2 (de) Verwendung einer Kombination von Antineoplastonen zur Herstellung eines Arzneimittels zur Behandlung der Neurofibromatose
DE2546001C3 (de) Immunostimulierende, Phospholipide enthaltende Stoffgemische, diese Stoffgemische enthaltende Arzneimittel und Verfahren zu ihrer Gewinnung
DE3141970C2 (ja)
DE3707127C2 (de) Verwendung von Methionin zur Behandlung von Immun-Schwächeerkrankungen bei Virusinfektionen und/oder bei Tumorerkrankungen
Lormans et al. Mebendazole (R 17 635) in Enterobiasis: A Clinical Trial in Mental Retardates
DE2215728A1 (de) Arzneimittel zur behandlung von herpes simplex
EP0561145A1 (de) Verwendung einer chemisch stabilisierten Chloritmatrix zur Herstellung von Arzneimitteln zur Behandlung von HIV-Infektionen

Legal Events

Date Code Title Description
8100 Publication of the examined application without publication of unexamined application
D1 Grant (no unexamined application published) patent law 81
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee